# Dantrolene in Statin-induced Myopathy

> **NCT06966843** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **Tanta University** · enrollment: 23 (estimated)

## Conditions studied

- Statins Induced Myopathy

## Interventions

- **DRUG:** Dantrolene
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06966843
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2027-10
- **Primary completion:** 2029-01
- **Final completion:** 2030-03
- **Target enrollment:** 23 (ESTIMATED)
- **Last updated:** 2025-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06966843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06966843, "Dantrolene in Statin-induced Myopathy". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT06966843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*